Yamamoto M - Search Results

1

Thalidomide dramatically improves the symptoms of early-onset sarcoidosis/Blau syndrome: its possible action and mechanism.

Yasui K, Yashiro M, Tsuge M, Manki A, Takemoto K, Yamamoto M, Morishima T. Yasui K, et al. Among authors: yamamoto m. Arthritis Rheum. 2010 Jan;62(1):250-7. doi: 10.1002/art.25035. Arthritis Rheum. 2010. PMID: 20039400 Free article.

2

Fluctuating liver functions in siblings with MPV17 mutations and possible improvement associated with dietary and pharmaceutical treatments targeting respiratory chain complex II.

Kaji S, Murayama K, Nagata I, Nagasaka H, Takayanagi M, Ohtake A, Iwasa H, Nishiyama M, Okazaki Y, Harashima H, Eitoku T, Yamamoto M, Matsushita H, Kitamoto K, Sakata S, Katayama T, Sugimoto S, Fujimoto Y, Murakami J, Kanzaki S, Shiraki K. Kaji S, et al. Among authors: yamamoto m. Mol Genet Metab. 2009 Aug;97(4):292-6. doi: 10.1016/j.ymgme.2009.04.014. Epub 2009 May 12. Mol Genet Metab. 2009. PMID: 19520594

3

Vitamin D deficiency in two young adults with biochemical findings resembling pseudohypoparathyroidism type I and type II.

Seki T, Yamamoto M, Kimura H, Tsuiki M, Ono M, Miki N, Takano K, Sato K. Seki T, et al. Among authors: yamamoto m. Endocr J. 2010;57(8):735-44. doi: 10.1507/endocrj.k10e-097. Epub 2010 May 25. Endocr J. 2010. PMID: 20505259 Free article.

4

Impact of Antithrombotic Drug Continuation on Postoperative Outcomes in Patients with Carpal Tunnel Syndrome: A Randomised, Open-Label, Parallel Group Trial.

Tsuchihashi A, Natsume T, Yamamoto M. Tsuchihashi A, et al. Among authors: yamamoto m. J Hand Surg Asian Pac Vol. 2024 Dec 27. doi: 10.1142/S2424835525500146. Online ahead of print. J Hand Surg Asian Pac Vol. 2024. PMID: 39725552

5

TIM3 on natural killer cells regulates antibody-dependent cellular cytotoxicity in HER2-positive gastric cancer.

Tsutsumi C, Ohuchida K, Tsutsumi H, Shimada Y, Yamada Y, Son K, Hayashida S, Katayama N, Mochida Y, Iwamoto C, Torata N, Horioka K, Shindo K, Mizuuchi Y, Ikenaga N, Nakata K, Ota K, Iwama E, Yamamoto M, Tsukamoto T, Nomura S, Morisaki T, Oda Y, Okamoto I, Nakamura M. Tsutsumi C, et al. Among authors: yamamoto m. Cancer Lett. 2024 Dec 23:217412. doi: 10.1016/j.canlet.2024.217412. Online ahead of print. Cancer Lett. 2024. PMID: 39722406

6

[A Case of Hepatocellular Carcinoma with Simultaneous Bone Metastasis Successfully Treated with Multidisciplinary Therapy].

Goto T, Sawada S, Ishida K, Ko R, Iwasaki Y, Nakanishi N, Morino K, Shimoike N, Tanaka H, Matsusue R, Yamamoto M, Machimoto T. Goto T, et al. Among authors: yamamoto m. Gan To Kagaku Ryoho. 2024 Dec;51(12):1243-1245. Gan To Kagaku Ryoho. 2024. PMID: 39721786 Japanese.

7

A Novel Series of Coumarin Derivatives That Exert Osteoblastogenic Effects in Mesenchymal Stem Cells and Osteogenic Effects in Ovariectomized Female Rats.

Takashima S, Morishita K, Yamamoto M, Ando M, Kawai S, Otake K, Shoji Y, Hinoi E, Kitao T, Shirahase H. Takashima S, et al. Among authors: yamamoto m. Chem Pharm Bull (Tokyo). 2024;72(12):1084-1104. doi: 10.1248/cpb.c24-00559. Chem Pharm Bull (Tokyo). 2024. PMID: 39721699 Free article.

8

Booster COVID-19 mRNA vaccination ameliorates impaired B-cell but not T-cell responses in older adults.

Kometani K, Yorimitsu T, Jo N, Yamaguchi E, Kikuchi O, Fukahori M, Sawada T, Tsujimoto Y, Sunami A, Li M, Ito T, Pretemer Y, Gao Y, Hidaka Y, Yamamoto M, Kaku N, Nakagama Y, Kido Y, Grifoni A, Sette A, Nagao M, Morita S, Nakajima TE, Muto M, Hamazaki Y. Kometani K, et al. Among authors: yamamoto m. Front Immunol. 2024 Dec 9;15:1455334. doi: 10.3389/fimmu.2024.1455334. eCollection 2024. Front Immunol. 2024. PMID: 39717779 Free PMC article.

9

Efficacy of Continuous Positive Airway Pressure Therapy in a Patient With Saber-Sheath Trachea on Dilated Central and Peripheral Airways: A Case Report.

Yamamoto M, Ikeuchi T, Touge H, Tomita K, Yamasaki A. Yamamoto M, et al. Cureus. 2024 Nov 22;16(11):e74266. doi: 10.7759/cureus.74266. eCollection 2024 Nov. Cureus. 2024. PMID: 39717320 Free PMC article.

10

Anticancer Effect of C19-Position Substituted Geldanamycin Derivatives Targeting NRF2-NQO1-activated Esophageal Squamous Cell Carcinoma.

Oshikiri H, Taguchi K, Hirose W, Taniyama Y, Kamei T, Siegel D, Ross D, Kitson RRA, Baird L, Yamamoto M. Oshikiri H, et al. Among authors: yamamoto m. Mol Cell Biol. 2024 Dec 24:1-19. doi: 10.1080/10985549.2024.2438817. Online ahead of print. Mol Cell Biol. 2024. PMID: 39717011

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,348 results

Search Page

Filters